Matinas BioPharma Hldgs Stock (AMEX: MTNB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 34.65K |
Day Range | - - - |
52 Wk Range | 3.28 - 44.50 |
Market Cap | $18.51M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 28 |
Short Interest | 59.02% |
Days to Cover | 1.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Matinas BioPharma Hldgs (AMEX:MTNB) through any online brokerage.
Other companies in Matinas BioPharma Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Evaxion Biotech (NASDAQ:EVAX).
Matinas BioPharma Hldgs has a consensus price target of $3.00.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $3.69 last updated September 20, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.